Role of MRI in the Early Diagnosis and Management of Acute Stroke and Its Impact on Turnaround Time in Emergency Settings

The Role of MRI in the Early Diagnosis and Management of Acute Stroke and Its Impact on Turnaround Time (TAT) in Emergency Settings

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07138768

Enrollment

136

Registered

2025-08-24

Start date

2025-08-23

Completion date

2026-12-01

Last updated

2025-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Stroke, Diagnosis, Emergency Settings, Magnetic Resonance Imaging, Management, Turnaround Time

Brief summary

This study aims to evaluate the role of stroke protocol in the early diagnosis and management of acute stroke and its effect on turnaround time (TAT) in emergency settings.

Detailed description

Acute stroke is a common and often devastating disorder; however, acute treatments that reduce long-term disability are available if patients present within the time window for treatment. Computed tomography (CT) or magnetic resonance imaging (MRI) has been used in comprehensive stroke centers, although the role of advanced imaging in the improvement of stroke outcome remains controversial. MRI offers advantages for the assessment of acute stroke. Changes of acute ischaemic injury are detectable sooner with MRI than with CT, especially with diffusion-weighted imaging, and ischaemic stroke diagnosis with MRI has greater interobserver and intraobserver reliability than CT, even in readers with little experience.

Interventions

DEVICEMagnetic Resonance Imaging

Magnetic Resonance Imaging will be performed to all patients

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age ≥18 years. * Both sexes. * Patients with acute stroke who are admitted to the emergency department.

Exclusion criteria

* Contraindications to magnetic resonance imaging (MRI) or computed tomography (CT). * Symptoms strongly suggestive of subarachnoid hemorrhage. * Initiation of antithrombotic or thrombolytic treatment before the completion of both scans. * Inability to complete both scans in time to allow thrombolytic treatment within three h of the onset of symptoms. * Uncontrollable hypertension. * Pregnant or lactating women.

Design outcomes

Primary

Measure	Time frame	Description
Sensitivity of magnetic resonance imaging for acute stroke	Immediately post-procedure (Up to 1 hour)	Sensitivity of magnetic resonance imaging for acute stroke will be recorded.

Countries

Egypt

Contacts

Primary ContactHend M Mansour, MD

hend.mansour@med.tanta.edu.eg00201221474344

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026